Antiatherosclerotic effects of β-blockers

American Journal of Cardiology

Volumn 91, Issue 12 SUPPL. 1, 2003, Pages 25-29

  Wikstrand, John ^a,b   Berglund, Göran ^c   Hedblad, Bo ^c   Hulthe, Johannes ^a  

^a ASTRAZENECA R AND D   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; PLACEBO; STATIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY DISEASE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED DRUG RELEASE; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; INTIMA; LONG TERM CARE; PRIORITY JOURNAL; SYMPATHETIC TONE; SYMPTOM; ULTRASOUND; VASCULAR ENDOTHELIUM;

EID: 0038344675     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00431-4     Document Type: Article

References (29)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 344:1994;1383-1389.
2. Wikstrand J., Kendall M., Berglund G. Metoprolol versus thiazide diuretics in hypertension: results from the MAPHY study in perspective. Black H. Clinical Trials in Hypertension. 2001;141-158 Marcel-Dekker Inc, New York.
3. Wikstrand J., Kendall M. The role of β receptor blockade in preventing sudden death. Eur Heart J. 13:(suppl D):1992;111-120.
4. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
5. Blankenhorn D.H., Selzer R.H., Crawford D.W., Barth J.D., Liu C.R., Liu C.H., Mack W.J., Alaupovic P. Beneficial effects of colestipol-niacin therapy on the common carotid artery two- and four-year reduction in intima media thickness measured by ultrasound . Circulation. 88:1993;20-28.
6. Crouse J.R., Byington R.P., Bond M.G., Espeland M.A., Craven T.E., Sprinkle J.W., McGovern M.E., Furberg C.D. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol. 75:1995;455-459.
7. Furberg C.D., Adams H.P. Jr, Appelgate W.B., Byington R.P., Espeland M.A., Hartwell T., Hunninghake D.B., Lefkowitz D.S., Probstfield J., Riley W.A., et al. Effects of lovastatin on early carotid atherosclerosis and cardiovascular events Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group . Circulation. 90:1994;1679-1687.
8. Wendelhag I., Wiklund O., Wikstrand J. Intima-media thickness after cholesterol lowering in familial hypercholesterolemia a three-year ultrasound study of common carotid and femoral arteries . Atherosclerosis. 117:1995;225-236.
9. Lonn E., Yusuf S., Dzavik V., Doris C., Yi Q., Smith S., Moore-Cox A., Bosch J., Riley W., Teo K. Effects of ramipril and vitamin E on atherosclerosis the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE) . Circulation. 103:2001;919-925.
10. Kaplan J.R., Manuck S.B. Status, stress and atherosclerosis the role of environment and individual behavior . Ann N Y Acad Sci. 896:1999;145-161.
11. Åblad B., Björkman J.A., Gustafsson D., Hansson G., Ostlund-Lindqvist A.M., Pettersson K. The role of sympathetic activity in atherogenesis effects of β-blockade . Am Heart J. 116:1988;322-327.
12. Östlund-Lindqvist A.M., Lindqvist P., Brautigam J., Olsson G., Bondjers G., Nordborg C. Effect of metoprolol on diet-induced atherosclerosis in rabbits. Arteriosclerosis. 8:1988;40-45.
13. Helin P., Lorenzen I., Garbarsch C., Matthiessen M.E. Arteriosclerosis in rabbit aorta induced by noradrenaline the importance of the duration of the noradrenaline action . Atherosclerosis. 12:1970;125-132.
14. Vesselinovitch D., Mullan J.F., Wissler R.W., Davis H.R., Brindenstine T. Carotid atherogenesis inhibited by sympathectomy, propranolol and nifedipine in rhesus monkeys [abstract]. Arteriosclerosis. 6:1986;561.
15. Björk-Skantze H., Kaplan J., Pettersson K., Manuck S., Blomqvist N., Kyes R., Williams K., Bondjers G. Psychosocial stress causes endothelial injury in cynomolgus monkeys via β1-adrenoceptor activation. Atherosclerosis. 136:1998;153-161.
16. Pettersson K., Bejne B., Björk H., Strawn W.B., Bondjers G. Experimental sympathetic activation causes endothelial injury in the rabbit thoracic aorta via β1-adrenoceptor activation. Circ Res. 67:1990;1027-1034.
17. Kaplan J.R., Manuck S.B., Adams M.R., Weingand K.W., Clarkson T.B. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation. 76:1987;1364-1372.
18. Lindén T., Camejo G., Wiklund O., Warnold I., Olofsson S.O., Bondjers G. Effect of short term β blockade on serum lipid levels and on the interaction of LDL with human arterial proteoglycans. J Clin Pharmacol. 30:(suppl):1990;S124-S131.
19. Hedblad B., Wikstrand J., Janzon L., Wedel H., Berglund G. Low dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS) . Circulation. 103:2001;1721-1726.
20. Wiklund O., Hulthe J., Wikstrand J., Schmidt C., Olofsson S.-O., Bondjers G. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia a 3-year randomized study . Stroke. 33:2002;572-577.
21. Berglund G., Elmståhl S., Janzon L., Larsson S.A. The Malmö Diet and Cancer Study design and feasibility . J Intern Med. 233:1993;45-51.
22. Whittington-Coleman P.J., Carrier O., Douglas B.H. The effects of propranolol on cholesterol-induced atheromatous lesions. Atherosclerosis. 18:1973;337-345.
23. Reinis Z., Lojda Z., Heyrovsky A., Horakova D., Reisenaver R. Effects of β-blocking agents in experimental atherosclerosis of cocks. Rev Czech Med. 22:1976;117-126.
24. Pettersson K., Hansson G., Björkman J.A., Åblad B. Prostacyclin synthesis in relation to sympathoadrenal activation effects of β-blockade . Circulation. 84:(suppl):1991;VI38-VI43.
25. Pettersson K., Björk H. Inhibition of platelet accumulation by β1-adrenoceptor blockade in the thoracic aorta of rabbits subjected to experimental sympathetic activation. Cardiovasc Drugs Ther. 6:1992;505-511.
26. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 157:1997;2413-2446.
27. Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction an overview of results from randomized controlled trials . JAMA. 270:1993;1589-1595.
28. The Cardiac Insufficiency Bisoprolol Study II (CIBIS II) a randomised trial . Lancet. 353:1999;9-13.
29. Packer M., Coats J.S., Fowler M.B., Katus H.A., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Roecker E.B., Schultz M.K., DeMets D.L. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658.